(Press-News.org) Scientists at the Walter and Eliza Hall Institute and their collaborators have tailor-made a new chemical compound that blocks a protein that has been linked to poor responses to treatment in cancer patients.
The development of the compound, called WEHI-539, is an important step towards the design of a potential new anti-cancer agent.
WEHI-539 has been designed to bind and block the function of a protein called BCL-XL that normally prevents cells from dying. The death and elimination of abnormal cells in the body is an important safeguard against cancer development. But cancer cells often acquire genetic changes that allow them to bypass cell death, which also reduces the effectiveness of anti-cancer treatments such as chemotherapy.
Cancer cells can become long-lived by producing high levels of BCL-XL protein, and high levels of BCL-XL are also associated with poorer outcomes for patients with lung, stomach, colon and pancreatic cancer.
Dr Guillaume Lessene, Professor Keith Watson and Professor David Huang from the institute's ACRF Chemical Biology division, and Dr Peter Czabotar and Professor Peter Colman from the institute's Structural Biology division led the development of WEHI-539 in collaboration with colleagues at Genentech, a member of the Roche group. The research is published online today in the journal Nature Chemical Biology.
Dr Lessene said the development of WEHI-539 was an important milestone on the way to creating potential anti-cancer agents that act to restore cell death by inhibiting BCL-XL. "Although WEHI-539 is not optimised for use in patients, it will be a very valuable tool for researchers to use to dissect how BCL-XL controls cancer cell survival," he said.
WEHI-539 belongs to a class of chemicals called 'BH3-mimetics', which all bind to the same region of BCL-XL or related proteins. Two BH3-mimetics, called navitoclax (ABT-263) and ABT-199/GDC-0199 are currently in clinical trials for the treatment of cancer, particularly those of the blood and lymph glands (leukaemia and lymphoma).
Dr Lessene said WEHI-539 was the product of a sustained research program. "We were very excited to see the team's work culminate in a compound that specifically inhibits BCL-XL," he said. "WEHI-539 is the first compound that our chemists have developed from scratch, using the three-dimensional structure of BCL-XL to build and refine its design."
INFORMATION:
The research was supported by the Australian Research Council, the National Health and Medical Research Council, the US Leukemia and Lymphoma Society, Cancer Council Victoria, the Australian Cancer Research Foundation and the Victorian Government.
Discovery brings hope of new tailor-made anti-cancer agents
2013-04-22
ELSE PRESS RELEASES FROM THIS DATE:
Even a few cigarettes a day increases risk of rheumatoid arthritis
2013-04-22
Number of cigarettes smoked a day and the number of years a person has smoked both increase the risk of rheumatoid arthritis (RA), finds research in BioMed Central's open access journal Arthritis Research & Therapy. The risk decreases after giving up smoking but, compared to people who have never smoked, this risk is still elevated 15 years after giving up.
Researchers from the Karolinska Institutet and Karolinska University Hospital analysed data from the Swedish Mammography Cohort, which included 34,000 women aged between 54 and 89, 219 of which had RA. Results of ...
Genetics defines a distinct liver disease
2013-04-22
Researchers have newly associated nine genetic regions with a rare autoimmune disease of the liver known as primary sclerosing cholangitis (PSC). This brings the total number of genetic regions associated with the disease to 16.
Approximately 70 per cent of people who suffer from PSC also suffer from IBD. The team showed that only half of the newly associated genetic regions were shared with inflammatory bowel disease (IBD). For the first time, this definitively proves that PSC, although genetically related to IBD, is a distinct disease.
PSC is a chronic, progressive ...
A check on tension
2013-04-22
April 21, 2013, New York, NY and San Diego Calif. – Ludwig researchers Arshad Desai and Christopher Campbell, a post-doctoral fellow in his laboratory, were conducting an experiment to parse the molecular details of cell division about three years ago, when they engineered a mutant yeast cell as a control that, in theory, had no chance of surviving. Apparently unaware of this, the mutant thrived.
Intrigued, Campbell and Desai began exploring how it had defied its predicted fate. As detailed in the current issue of Nature, what they discovered has overturned the prevailing ...
Particular DNA changes linked with prostate cancer development and lethality
2013-04-22
A new analysis has found that the loss or amplification of particular DNA regions contributes to the development of prostate cancer, and that patients with two of these DNA changes have a high likelihood of dying from the disease. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study provides valuable information on the genetics of prostate cancer and offers insights into which patients should be treated aggressively.
Cells can become cancerous when they lose or amplify pieces of DNA containing important genes. Using a method ...
After age 18, asthma care deteriorates
2013-04-22
It is widely accepted that medical insurance helps older adults with chronic health problems to receive better care. But what about young adults between the ages of 18 and 25, a demographic that also tends to have the lowest levels of health insurance coverage?
In what may be the first study to measure health care utilization patterns among young adults with chronic health problems—in this case asthma—a team of researchers at Harvard Medical School found that losing health insurance was a significant predictor of deteriorating patterns of health management. Other social ...
Positive effect of white button mushrooms when substituted for meat on body weight and composition changes during weight loss and weight maintenance
2013-04-22
New research published as an abstract in The FASEB Journal and presented at Experimental Biology 2013 (EB 2013) on Monday, April 22 ties mushrooms to positive health outcomes in the area of weight management. A one-year, randomized clinical trial conducted by researchers at the Weight Management Center at Johns Hopkins Bloomberg School of Public Health and funded by the Mushroom Council found that substituting white button mushrooms for red meat can be a useful strategy for enhancing and maintaining weight loss.1
Participants included obese adults (73 adults; 88% women; ...
New research constructs ant family tree
2013-04-22
Anyone who has spent time in the tropics knows that the diversity of species found there is astounding and the abundance and diversity of ants, in particular, is unparalleled. Scientists have grappled for centuries to understand why the tropics are home to more species of all kinds than the cooler temperate latitudes on both sides of the equator. Several hypotheses have been proposed to explain the higher species numbers in the tropics, but these hypotheses have never been tested for the ants, which are one of the most ecologically and numerically dominant groups of animals ...
Germanium made laser compatible
2013-04-22
Researchers from ETH Zurich, the Paul Scherrer Institute (PSI) and the Politec-nico di Milano have jointly developed a manufacturing technique to render the semiconductor germanium laser-compatible through high tensile strain. In their article recently published in "Nature Photonics", they reveal how they can gen-erate the necessary tensile strain efficiently. The scientists demonstrate how to use their method to effectively alter the optical properties of germanium, which is naturally unsuitable for lasing: "With a strain of three per cent, the material emits around twenty-five ...
Using nitrous oxide for anesthesia doesn't increase -- and may decrease -- complications and death
2013-04-22
But an accompanying series of editorials points out some important limitations of the two studies—which can't completely overcome previous concerns about the safety of using nitrous oxide (N2O) as a surgical anesthetic.
Is Nitrous Oxide Safe for Surgical Anesthesia?
Nitrous oxide is the world's oldest general anesthetic, but there's a long history of debate regarding its appropriate role in modern surgical anesthesia. Although nitrous oxide provides effective sedation and pain control, it has known disadvantages and side effects. A previous study, called "ENIGMA-I," ...
Marketing Rockstar's Guide to Marketo Released to Help B2B Marketers Make the Most of Marketing Automation
2013-04-22
Josh Hill, an experienced business-to-business marketer announced availability of the Marketing Rockstar's Guide to Marketo, an independent project aimed at marketers who are new to the marketing automation tool Marketo.
Josh started the project to keep track of the many ways Marketo can be used as well as best practice setup techniques. Having gone through previous Marketo implementations with Salesforce.com, Josh believed there was a gap between Marketo documentation and marketers' technical skills.
"I work at the nexus of technology, marketing, and sales to ...